Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
2003.
Current awareness in geriatric psychiatry.
International Journal of Geriatric Psychiatry,
Vol. 18,
Issue. 7,
p.
661.
H. Greig, Nigel
Yu, Qian-sheng
Luo, Weiming
W. Holloway, Harold
Utsuki, Tada
Ann Perry, Tracy
K. Lahiri, Debomoy
and
Brossi, Arnold
2003.
Racemic N1-Norphenserine and Its Enantiomers: Unpredicted Inhibition of Human Acetyl- and Butyrylcholinesterase and β-Amyloid Precursor Protein in vitro.
HETEROCYCLES,
Vol. 61,
Issue. 1,
p.
529.
Standridge, John B
2004.
Pharmacotherapeutic approaches to the treatment of Alzheimer's disease.
Clinical Therapeutics,
Vol. 26,
Issue. 5,
p.
615.
Raygani, Asad Vaisi
Zahrai, Mahine
Soltanzadeh, Akbar
Doosti, Mahmood
Javadi, Ebrahim
and
Pourmotabbed, Tayebeh
2004.
Analysis of association between butyrylcholinesterase K variant and apolipoprotein E genotypes in Alzheimer's disease.
Neuroscience Letters,
Vol. 371,
Issue. 2-3,
p.
142.
Darvesh, Sultan
Martin, Earl
Walsh, Ryan
and
Rockwood, Kenneth
2004.
Differential effects of lipid-lowering agents on human cholinesterases.
Clinical Biochemistry,
Vol. 37,
Issue. 1,
p.
42.
Muñoz-Ruiz, Pilar
Rubio, Laura
García-Palomero, Esther
Dorronsoro, Isabel
del Monte-Millán, María
Valenzuela, Rita
Usán, Paola
de Austria, Celia
Bartolini, Manuela
Andrisano, Vincenza
Bidon-Chanal, Axel
Orozco, Modesto
Luque, F. Javier
Medina, Miguel
and
Martínez, Ana
2005.
Design, Synthesis, and Biological Evaluation of Dual Binding Site Acetylcholinesterase Inhibitors: New Disease-Modifying Agents for Alzheimer's Disease.
Journal of Medicinal Chemistry,
Vol. 48,
Issue. 23,
p.
7223.
Darvesh, Sultan
McDonald, Robert S.
Penwell, Andrea
Conrad, Sarah
Darvesh, Katherine V.
Mataija, Diane
Gomez, Geraldine
Caines, Angela
Walsh, Ryan
and
Martin, Earl
2005.
Structure–activity relationships for inhibition of human cholinesterases by alkyl amide phenothiazine derivatives.
Bioorganic & Medicinal Chemistry,
Vol. 13,
Issue. 1,
p.
211.
Standridge, John B.
2005.
Current Status and Future Promise of Pharmacotherapeutic Strategies for Alzheimer’s Disease.
Journal of the American Medical Directors Association,
Vol. 6,
Issue. 3,
p.
194.
Tasker, Andrea
Perry, Elaine K
and
Ballard, Clive G
2005.
Butyrylcholinesterase: impact on symptoms and progression of cognitive impairment.
Expert Review of Neurotherapeutics,
Vol. 5,
Issue. 1,
p.
101.
Janas, Anne M.
Cunningham, Steven C.
Duffy, Kara B.
Devan, Bryan D.
Greig, Nigel H.
Holloway, Harold W.
Yu, Quian-Sheng
Markowska, Alicja L.
Ingram, Donald K.
and
Spangler, Edward L.
2005.
The cholinesterase inhibitor, phenserine, improves Morris water maze performance of scopolamine-treated rats.
Life Sciences,
Vol. 76,
Issue. 10,
p.
1073.
LAHIRI, DEBOMOY K.
CHEN, DE‐MAO
LAHIRI, PREETI
BONDY, STEVE
and
GREIG, NIGEL H.
2005.
Amyloid, Cholinesterase, Melatonin, and Metals and Their Roles in Aging and Neurodegenerative Diseases.
Annals of the New York Academy of Sciences,
Vol. 1056,
Issue. 1,
p.
430.
Standridge, John B.
2005.
Current Status and Future Promise of Pharmacotherapeutic Strategies for Alzheimer’s Disease.
Journal of the American Medical Directors Association,
Vol. 6,
Issue. 3,
p.
194.
Aisen, Paul S.
2005.
Emerging treatment strategies for alzheimer’s disease.
Current Psychosis & Therapeutics Reports,
Vol. 3,
Issue. 1,
p.
15.
-Rahman, Atta-ur
Khalid, Asaad
Sultana, Nighat
Nabeel Ghayur, M.
Ahmed Mesaik, M.
Riaz Khan, M.
Gilani, Anwar H.
and
Iqbal Choudhary, M.
2006.
New natural cholinesterase inhibiting and calcium channel blocking quinoline alkaloids.
Journal of Enzyme Inhibition and Medicinal Chemistry,
Vol. 21,
Issue. 6,
p.
703.
Narayanan, Siva
Beusterien, Kathleen M.
Thomas, Simu K.
Musher, Jonathan
and
Strunk, Bill
2006.
Antipsychotic Drug Use Among Nursing Home Residents Taking Rivastigmine.
Journal of the American Medical Directors Association,
Vol. 7,
Issue. 1,
p.
12.
Ahmed, Mushtaq
Rocha, João Batista T.
Corrêa, Maísa
Mazzanti, Cinthia M.
Zanin, Rafael F.
Morsch, André L.B.
Morsch, Vera Maria
and
Schetinger, Maria R.C.
2006.
Inhibition of two different cholinesterases by tacrine.
Chemico-Biological Interactions,
Vol. 162,
Issue. 2,
p.
165.
Kamal, Mohammad A.
Al-Jafari, Abdulaziz A.
Yu, Qian-Sheng
and
Greig, Nigel H.
2006.
Kinetic analysis of the inhibition of human butyrylcholinesterase with cymserine.
Biochimica et Biophysica Acta (BBA) - General Subjects,
Vol. 1760,
Issue. 2,
p.
200.
Standridge, John B.
2006.
Current Status and Future Promise of Pharmacotherapeutic Strategies for Alzheimer’s Disease.
Journal of the American Medical Directors Association,
Vol. 7,
Issue. 3,
p.
S46.
Martinez, Ana
and
Castro, Ana
2006.
Novel cholinesterase inhibitors as future effective drugs for the treatment of Alzheimer’s disease.
Expert Opinion on Investigational Drugs,
Vol. 15,
Issue. 1,
p.
1.
Kwon, Young Ee
Park, Jung Youl
No, Kyung Tai
Shin, Jae Hong
Lee, Sung Kwang
Eun, Jae Soon
Yang, Jae Heon
Shin, Tae Yong
Kim, Dae Keun
Chae, Byung Sook
Leem, Jae-Yoon
and
Kim, Kuk Hwan
2007.
Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Aβ1–42 aggregation for Alzheimer’s disease therapeutics.
Bioorganic & Medicinal Chemistry,
Vol. 15,
Issue. 20,
p.
6596.